Millennium Management Portfolio holdings
Millennium Management, founded in 1989 by Israel (Izzy) Englander and Ronald Shear and headquartered in New York City, is a global multi-strategy hedge fund managing over $71 billion in assets as of late 2024, employing a decentralized model with over 300 independent trading teams. Operating across equities, fixed income, commodities, currencies, and derivatives, the firm uses a mix of quantitative and fundamental strategies, providing its portfolio managers with capital, infrastructure, and autonomy to pursue diverse investment approaches while enforcing strict risk management. With more than 5,400 employees across offices in London, Hong Kong, Singapore, and beyond, Millennium has evolved from its initial $35 million seed capital—partly from the Belzberg family—into a titan of the hedge fund world, known for its ability to attract top talent and deliver consistent returns. Under Englander’s leadership as chairman and CEO, the firm remains a low-profile yet highly influential force in global finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$1.78B |
| 2 |
Apple
AAPL
|
+$1.13B |
| 3 |
ETHA
iShares Ethereum Trust ETF
ETHA
|
+$834M |
| 4 |
iShares Core S&P 500 ETF
IVV
|
+$784M |
| 5 |
Norfolk Southern
NSC
|
+$613M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Applovin
APP
|
+$1.19B |
| 2 |
Palantir
PLTR
|
+$742M |
| 3 |
HES
Hess
HES
|
+$478M |
| 4 |
Oracle
ORCL
|
+$465M |
| 5 |
Thomson Reuters
TRI
|
+$442M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 9.28% |
| 2 | Financials | 7.68% |
| 3 | Healthcare | 6.5% |
| 4 | Industrials | 5.87% |
| 5 | Consumer Discretionary | 4.48% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ADVM
4201
DELISTED
Adverum Biotechnologies
ADVM
| $1.47M | ﹤0.01% |
324,422
-17,918
| -5% | -$52.8K |
|
4202
CALL
MasTec
MTZ
$21B
| $1.47M | ﹤0.01% |
6,900
+100
| +1% | +$18.3K |
|
|
QIPT
4203
DELISTED
Quipt Home Medical
QIPT
| $1.47M | ﹤0.01% |
562,532
-16,966
| -3% | -$39.2K |
|
4204
Redwire
RDW
$2.3B
| $1.47M | ﹤0.01% |
163,230
-1,140,314
| -87% | -$13.3M |
|
4205
World Acceptance Corp
WRLD
$877M
| $1.47M | ﹤0.01% |
+8,667
| New | +$1.46M |
|
4206
CALL
Amprius Technologies Warrants
AMPX.WS
$436M
| $1.46M | ﹤0.01% |
+400,000
| New | +$854K |
|
4207
RadNet
RDNT
$5.25B
| $1.46M | ﹤0.01% |
19,199
-310,406
| -94% | -$20.2M |
|
4208
PUT
CarMax
KMX
$8.29B
| $1.46M | ﹤0.01% |
32,600
+4,200
| +15% | +$251K |
|
4209
Invesco KBW Bank ETF
KBWB
$6.83B
| $1.46M | ﹤0.01% |
+18,689
| New | +$1.41M |
|
|
UCTT
4210
Ultra Clean Holdings
UCTT
$4B
| $1.46M | ﹤0.01% |
53,592
-28,396
| -35% | -$698K |
|
4211
Capricor Therapeutics
CAPR
$243M
| $1.46M | ﹤0.01% |
202,459
+28,611
| +16% | +$211K |
|
4212
Solid Power
SLDP
$479M
| $1.46M | ﹤0.01% |
420,170
+161,634
| +63% | +$609K |
|
4213
CALL
Joby Aviation
JOBY
$7.26B
| $1.46M | ﹤0.01% |
204,033
-82,000
| -29% | -$1.25M |
|
4214
Kimbell Royalty Partners
KRP
$1.46B
| $1.45M | ﹤0.01% |
107,724
-118,534
| -52% | -$1.67M |
|
4215
CALL
VF Corp
VFC
$5.87B
| $1.45M | ﹤0.01% |
100,400
+3,500
| +4% | +$47K |
|
4216
Atossa Therapeutics
ATOS
$21.6M
| $1.45M | ﹤0.01% |
111,243
-25,259
| -19% | -$312K |
|
|
TLN
4217
PUT
Talen Energy Corp
TLN
$16.5B
| $1.45M | ﹤0.01% |
+3,400
| New | +$1.23M |
|
|
4218
CALL
Capricor Therapeutics
CAPR
$243M
| $1.45M | ﹤0.01% |
200,500
+160,500
| +401% | +$1.18M |
|
4219
PUT
DoubleVerify
DV
$1.8B
| $1.44M | ﹤0.01% |
+120,000
| New | +$1.78M |
|
4220
Stoke Therapeutics
STOK
$1.84B
| $1.43M | ﹤0.01% |
61,048
+40,652
| +199% | +$697K |
|
4221
PUT
Takeda Pharmaceutical
TAK
$53.7B
| $1.43M | ﹤0.01% |
+97,800
| New | +$1.45M |
|
4222
Esquire Financial Holdings
ESQ
$1.12B
| $1.43M | ﹤0.01% |
+14,026
| New | +$1.38M |
|
4223
TFS Financial
TFSL
$5.17B
| $1.43M | ﹤0.01% |
108,628
+44,171
| +69% | +$584K |
|
4224
CALL
Nektar Therapeutics
NKTR
$2.38B
| $1.42M | ﹤0.01% |
25,000
-54,000
| -68% | -$1.79M |
|
|
JAMF
4225
CALL
DELISTED
Jamf
JAMF
| $1.42M | ﹤0.01% |
+132,900
| New | +$1.2M |
|
Similar funds
Millennium Management's Q3 2025 Portfolio in Review
As of Q3 2025, Millennium Management held 6,610 positions worth $234B, up 13% from $207B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Millennium Management's Q3 2025 filing shows 800 new, 2,296 increased, 2,513 reduced and 633 closed positions. Its largest new stake was Vanguard Long-Term Corporate Bond ETF: 1,212,092 shares worth $94.1M. The largest sale was Applovin, an estimated $1.19B.
By sector, the portfolio is most concentrated in Technology at 9.3% of assets, up from 8.7% a quarter earlier, followed by Financials and Healthcare.
- Millennium Management's largest Q3 2025 buy was Vanguard Long-Term Corporate Bond ETF: 1,212,092 shares worth $94.1M.
- Millennium Management added most to NVIDIA in Q3 2025, an estimated $1.78B increase.
- Millennium Management's biggest Q3 2025 reduction was Applovin, cutting an estimated $1.19B.
- Millennium Management fully exited Hess in Q3 2025, selling an estimated $478M.
- Millennium Management's ten largest holdings make up 18% of its $234B portfolio in Q3 2025.
- Millennium Management opened 800 new positions and closed 633 in Q3 2025.
- Millennium Management's portfolio value rose 13% quarter-over-quarter to $234B.
Based on Millennium Management's 13F filing for Q3 2025, filed 14 Nov 2025.